Quote:

---

Question for the board. When we get an indication approved, say the ART-bNAB-LL combination drug HIV cure, could a board-certified doctor prescribe it for any off-label use, say Alzheimer's?

---

That's irrelevant because leronlimab will have an approval for a different disease long before ART/bNab/leronlimab goes through all the steps for approval in HIV. If continued funding occurs in the Alzheimer's space or Cytodyn chooses to go to trial in phase 2 Alzheimer's first than no off-label needed. Whatever the first approval it could be used off-label for any disease.